Diadema Partners »

Aprea Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 45k 0.80

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Aprea Therapeutics

AIGH Capital Management
Vestal Point Capital
Sphera Funds Management
Nantahala Capital Management
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Diadema Partners
Vanguard Fiduciary Trust
Susquehanna International
Vanguard Capital Management
Morgan Stanley
LPL Financial
HighTower Advisors

View all funds holding Aprea Therapeutics